Concepedia

Miguel Hominal

MH

Statistics

Publications

19

Citations

7.3K

H-Index

18

Active since

2013

Affiliations

Brigham and Women's Hospital(Current)

Population Health Research Institute

Harvard University

University of Edinburgh

McMaster University

Miguel Hominal is an author at Brigham and Women's Hospital specializing in medicine, cardiovascular pharmacotherapy, and cardiology.

Publications per year

2013–2025

19

Publications

19

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

, , +14

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

, , +12

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

, , +13

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

, , +15

Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study

Hisham Dokainish, Koon Teo, Jun Zhu et al. · The Lancet Global Health · 2017 · 401 citations · Full text

, , +14

1–5 of 19